MedTrace Logo

GMMG Multiple Myeloma Registry

NCT07111884 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 999

Last updated 2025-08-08

No results posted yet for this study

Summary

The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Group (GMMG). Target variables of interest are:

Overall survival, progression-free survival and follow-up time.

The relevant registry data will be provided and evaluated together with the therapy study data for scientific research projects.

This allows seamless documentation of patient data from the end of the trial to long-term follow-up.

Conditions

Sponsors & Collaborators

  • Dietmar Hopp Stiftung

    collaborator OTHER

  • KKS Netzwerk

    collaborator NETWORK

  • German Cancer Research Center

    collaborator OTHER

  • Prof. Dr. Hartmut Goldschmidt

    lead OTHER

Principal Investigators

  • Hartmut Goldschmidt, Prof. · University Hospital Heidelberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-08
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07111884 on ClinicalTrials.gov